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Graded gene expression changes
determine phenotype severity in mouse
models of CRX-associated retinopathies
Philip A. Ruzycki1,3†, Nicholas M. Tran1,3,4†, Vladimir J. Kefalov1, Alexander V. Kolesnikov1 and Shiming Chen1,2,3*
Abstract
Background: Mutations in the cone-rod-homeobox protein CRX are typically associated with dominant blinding
retinopathies with variable age of onset and severity. Five well-characterized mouse models carrying different Crx
mutations show a wide range of disease phenotypes. To determine if the phenotype variability correlates with
distinct changes in CRX target gene expression, we perform RNA-seq analyses on three of these models and
compare the results with published data.
Results: Despite dramatic phenotypic differences between the three models tested, graded expression changes in
shared sets of genes are detected. Phenotype severity correlates with the down-regulation of genes encoding key
rod and cone phototransduction proteins. Interestingly, in increasingly severe mouse models, the transcription of
many rod-enriched genes decreases decrementally, whereas that of cone-enriched genes increases incrementally.
Unlike down-regulated genes, which show a high degree of CRX binding and dynamic epigenetic profiles in normal
retinas, the up-regulated cone-enriched genes do not correlate with direct activity of CRX, but instead likely reflect a
change in rod cell-fate integrity. Furthermore, these analyses describe the impact of minor gene expression changes
on the phenotype, as two mutants showed marginally distinguishable expression patterns but huge phenotypic
differences, including distinct mechanisms of retinal degeneration.
Conclusions: Our results implicate a threshold effect of gene expression level on photoreceptor function and survival,
highlight the importance of CRX in photoreceptor subtype development and maintenance, and provide a molecular
basis for phenotype variability in CRX-associated retinopathies.
Background
Rod and cone photoreceptors are the two primary light
detecting cell types of the retina and are essential for
vision. Each cell type preferentially expresses a set of genes
critical for development and maintenance of its specialized
function. This cell type-specific gene expression is reg-
ulated by a network of transcription factors (reviewed
in [1, 2]). Disruptions in this regulatory network can
have a dramatic effect on rod [3–6] and cone [7, 8] de-
velopment, function, cell-fate integrity and survival.
The homeodomain transcription factor CRX (Cone-rod
homeobox protein) is expressed in both rods and cones
and plays a central role in mediating photoreceptor tran-
scription. CRX works with rod-specific, cone-specific and
general transcription factors to control photoreceptor
gene expression [9–14]. In particular, CRX and the rod-
specific transcription factor NRL (Neural retina leucine
zipper protein) cooperatively regulate rod gene transcrip-
tion and have highly overlapping DNA-binding patterns
[15–17]. Loss of CRX dramatically impairs both rod and
cone photoreceptor gene transcription, leading to failed
photoreceptor maturation and rapid degeneration [18],
while the loss of NRL converts rods into cells with cone-
like transcription and functional properties [3, 16].
Mutations in the human CRX gene have been associated
with dominant forms of retinal degenerative diseases such
as retinitis pigmentosa, cone-rod dystrophy (CoRD) and
Leber congenital amaurosis (LCA), with varied age of
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onset and severity (reviewed in [14, 19, 20]). Disease-
causing mutations fall into at least four classes, based
on mutation type, pathogenic mechanism and molecular
properties of the mutant protein: I) hypomorphic substitu-
tion mutations with reduced DNA-binding activity; II)
antimorphic substitution mutations with variable DNA-
binding; III) antimorphic frameshift mutations with intact
DNA-binding; and IV) antimorphic frameshift muta-
tions with variable DNA-binding (reviewed in [14]).
While each class of disease-causing mutation is associ-
ated with distinct clinical phenotypes, the underlying
transcriptional changes mediating these phenotypes are
poorly understood.
In this study, we used mRNA sequencing (RNA-seq) to
examine gene expression in the developing and adult
retinas of three Crx mutation knock-in mouse models that
have distinct retinal phenotypes [21]: CrxR90W (R90W),
CrxE168d2 (E168d2) and CrxE168d2neo (E168d2neo) (Fig. 1,
Table 1). The R90W mice carry a class I mutation and
their phenotypes resemble mild late-onset dominant
CoRD and recessive LCA. E168d2 and E168d2neo mice
carry the same class III mutation but E168d2neo mice
express the mutant protein at a lower level, due to the
retention of an intronic neomycin cassette. E168d2
mouse phenotypes resemble severe dominant LCA,
while E168d2neo mouse phenotypes resemble a less
severe dominant CoRD phenotype, due to reduced
mutant protein expression. We assessed how each Crx
mutation impacted the expression of retinal cell type-
specific genes and investigated cellular pathways that
may contribute to disease. We correlated these tran-
scriptional changes with the direct DNA-binding activ-
ity of CRX [15] and NRL [17] and the epigenetic
landscape of rods and cones [22, 23]. Additionally, we
compared the expression profiles of these Crx knock-in
mice to the previously characterized Crx−/− and CrxRip
(Rip) mouse models. Rip mice carry a class IV mutation
and have a more severe dominant LCA phenotype than
E168d2 mice [24]. Our results demonstrate that all five
mouse models have graded changes in photoreceptor-
specific gene expression that correlate with the severity
of their phenotypes. These graded changes include
reduced expression of direct CRX target genes required
for rod/cone photoreceptor function and survival, and
derepression of ‘cone’ genes in rods through an indirect
mechanism, suggesting that rod cell-fate integrity is
compromised in the more severe models.
Lastly, we identified threshold effects of gene expres-
sion changes on retinal phenotype. Despite having only
small differences in gene expression changes, heterozy-
gous E168d2 and E168d2neo mice showed drastically
different phenotypes, including light-independent versus
light-dependent photoreceptor degeneration, respectively.
These phenotypic and mechanistic differences between
the two models are likely attributed to slight shifts in
gene expression throughout several photoreceptor-specific
pathways, particularly phototransduction and the retinoid
(visual) cycle. This highlights the delicate balance between
photoreceptor gene transcription, function and cellular
integrity. These results demonstrate that the transcrip-
tional landscape in models of retinal degeneration can
dramatically affect disease pathology. Effective therapeutic
design may therefore be highly context specific.
Results
Crx mutations cause graded expression changes in shared
gene sets, correlating with phenotype severity
To assess the effects of Crx mutations on retinal gene
expression we performed RNA-seq on retinas of the Crx
mutant mouse models R90W, E168d2 and E168d2neo, and
age-matched wild-type (WT) controls, in triplicate. As
listed in Table 2, we analyzed heterozygous mutants at
both postnatal day (P)10 and P21, but homozygous mu-
tants at P10 only, as their retinas are severely degenerated
at later ages. Because they lack WT CRX to antagonize the
antimorphic mutant CRX protein, homozygous E168d2
Fig. 1 Schematic diagram of wild-type (WT) and mutant CRX proteins made by the indicated mouse models. The WT CRX protein shown on the
top is 299 amino acids (A.A.) in length and contains the indicated DNA-binding and transactivation domains (indicated by bars above diagram)
and several conserved motifs (marked by solid grey and black boxes). The substitution mutation R90W lies within the homeodomain and reduces
DNA-binding [21]. The frameshift mutation E168d2 results in a C-terminus truncated CRX protein that retains DNA-binding capability but fails to
activate transcription, and is, therefore, antimorphic [21]. The frameshift mutation G255d1 ‘Rip’ results in a non-homologous C-terminal extension
(dark grey hashed box), creating an antimorphic protein that no longer binds DNA [24]. The phenotypes of heterozygous mice carrying each of
these mutations are summarized in Table 1
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and E168d2neo mice show essentially the same severe
phenotype at morphological, functional and gene ex-
pression levels [21] (Table S1a in Additional file 1).
Thus, we only performed RNA-seq on E168d2/d2 to
provide a reference for an extremely severe phenotype.
RNA-seq libraries were sequenced on the Illumina
HiSeq2000 and each generated more than 28 million
mapped reads (Additional file 2). Sample quality was
assessed by principal component analysis (PCA) of the
expression values of all genes that passed the 5 counts per
million (CPM) threshold in any genotype (Additional file
3), and by visual inspection of mapped reads at individual
gene loci using Integrated Genomics Viewer (IGV) [25]
(Figure S2a, b in Additional file 4). PCA plots (Additional
file 3) show that the genotypes clustered as expected with
the E168d2/d2 samples showing the most variation from
WT controls at both ages tested. At P10 E168d2/+,
E168d2neo/+ and R90W/W samples clustered between
WT and E168d2/d2, corresponding to their intermediate
phenotypes. In contrast, R90W/+ samples clustered with
WT samples, consistent with their normal phenotype at
this age. At P21, despite increased replicate variability, dif-
ferences between heterozygous mutant genotypes and
WT are consistent with their phenotypes. Since the PCA
analysis only described sample differences as a whole, we
further determined the relationship of gene expression
changes and phenotype differences, using multiple in-
dependent analyses of gene expression. First, to deter-
mine differential expression, EdgeR [26] was used to
compare the triplicate samples. Changes considered
“significant” were twofold or greater [fold change (FC)
≥ 2] with a false discovery rate (FDR) ≤ 0.05 from the
appropriate WT control, unless otherwise noted. Add-
itional filtering and analysis details can be found in the
"Materials and methods" section. Expression changes in
subsets of RNA-seq-identified genes were further vali-
dated using quantitative real time PCR (qRT-PCR;
Table S1a–c in Additional file 1).
Homozygous Crx mutant mice show drastically changed
expression of a large number of genes at P10 before
photoreceptor degeneration
We first compared retinal gene expression in the homo-
zygous mutants E168d2/d2 and R90W/W at P10 with
that in age-matched WT controls. As shown by the scat-
terplots (Fig. 2a, b), both mutants displayed twofold or
greater expression changes for a large number of genes.
However, the number of genes affected in E168d2/d2
was much larger than in R90W/W (Table 2). Among the
changed genes, down-regulated genes outnumbered up-
Table 1 Phenotype summary of heterozygous Crx mutant mice
Mousea Mutation
classb
CRX
expressionc
Rod Cone Disease
model
Phenotype
severityeFunctiond Degeneration Functiond Degeneration
WT NA + ++++ Undetectable ++++ Undetectable NA NA
R90W I + ++++ Undetectable ++++ Undetectable CoRD Mild
E168d2neo III + +++ Undetectable ++ ≥1 year CoRD Moderate
E168d2 III ++ ++ 1–6 months + 1 month LCA Severe
Rip IV + - 1–18 months - Undetectable LCA Very severe
a Heterozygous mice harboring the indicated Crx mutations [21, 24] are used for phenotype comparisons
b Classification described by [14]
c Grading based on quantitative western blots [21]. Note a twofold increase in E168d2 but normal level in others
d Grading based on reduction of electroretinography (ERG) peak amplitudes [21]. Dashes indicate undetected ERG signals
e Severity based on combined morphological and functional deficits
WT C57BL/6 J wild-type control, NA not applicable
Table 2 List of RNA-seq experiments and number of genes with altered expression
Mousea Experiments and replicatesb Down-regulated genesc Up-regulated genesc
P10 P21 P10 P21 P10 P21
WT 3 3 NA NA NA NA
E168d2/d2 3 Not tested 425 NA 248 NA
R90W/W 3 Not tested 195 NA 70 NA
E168d2/+ 3 3 136 150 61 43
E168d2neo/+ 3 3 85 83 38 19
R90W/+ 3 3 20 27 12 27
a All mutant mice were backcrossed to C57BL/6 J (WT) control for >10 generations and genotyped for common variants [21]
b Numbers represent biological replicates. Each replicate contains four pooled retinas from a male and female pair
c Numbers represent transcripts significantly altered (FC ≥ 2, FDR ≤ 0.05) relative to WT control
NA not applicable
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regulated genes (Table 2), consistent with the established
role of CRX in the activation of transcription. Some of
the affected genes (labeled in white in Fig. 2a, b) encode
well-characterized proteins essential for rod and cone
identity, function and survival. Next, we compared the
changed gene sets between the two mutants. Even
though E168d2/d2 and R90W/W have mechanistically
distinct mutant proteins and phenotypes [21], the signifi-
cantly affected (FC ≥ 2, FDR ≤ 0.05) genes showed a
high degree of overlap for both down-regulated and up-
regulated gene sets (Fig. 2c, d). In addition, for these
shared genes the degree of change was generally greater
in E168d2/d2 than in R90W/W, as seen by visually
inspecting the positions of the highlighted genes in
Fig. 2a versus Fig. 2b. These changes were confirmed to
be consistent between replicates by comparing the raw
mapped reads for several of these genes (Figure S2a in
Additional file 4). Homozygous mouse retina RNA-seq re-
sults for several genes were also consistent with previous
qRT-PCR data [21] (Table S1b in Additional file 1). These
data suggest that photoreceptor gene expression in
R90W/W is less disrupted than in E168d2/d2, consistent
with the phenotype differences between the two models.
Heterozygous Crx mutant mice have moderate expression
changes in fewer genes than the homozygous mutants at
P10, with few independently affected genes
To determine if heterozygous mutants also share gene
expression changes between genotypes, we compared
RNA-seq data from heterozygous mutants E168d2/+,
R90W/+, as well as E168d2neo/+. At P10, the heterozy-
gous mutants showed fewer gene changes than the re-
spective homozygous counterparts (Table 2). Similar to
the homozygous mutants, the number of significantly
affected genes in heterozygotes correlated with phenotype
severity in the order E168d2/+ > E168d2neo/+ > R90W/+.
Figure 3a–c and Figure S2a in Additional file 4 show that,
qualitatively, the white highlighted photoreceptor tran-
scripts were most severely affected in the E168d2/+
mutant, less affected in E168d2neo/+ and showed no
change greater than twofold in the R90W/+ line. Further-
more, affected transcripts in heterozygotes also showed a
high degree of overlap between the genotypes (Fig. 3d, e).
Next, we analyzed whether the degree of expression
changes correlates with phenotype severity. To gain
quantitative results for the entire datasets, we com-
pared the overall FC (relative to WT) for the union of
all affected genes (see Table 2 for total numbers) in
E168d2/+, E168d2neo/+ and R90W/+ mutants (Fig. 3f, g).
Both down-regulated (Fig. 3f) and up-regulated (Fig. 3g)
groups showed a stepwise pattern of expression fold
changes: E168d2/+ > E168d2neo/+ > R90W/+. Thus, in
addition to the number of affected genes, the degree of
expression changes also correlates with phenotype severity
in heterozygous mutants. While this difference in expres-
sion was statistically significant (Fig. 3f, g), the differences
between the median log2 FC for individual genes
expressed in the different heterozygotes were rather small.
This is in contrast to the large phenotype differences
between these genotypes (Table 1), demonstrating the
importance of precisely regulated gene expression for
photoreceptor integrity. The expression changes deter-
mined by RNA-seq of a subset of genes were validated to
be consistent between replicates (Figure S2a in Additional
file 4) and accordant with previous qRT-PCR data [21]
(Table S1b, c in Additional file 1).
Fig. 2 RNA-seq analyses describe overlapping sets of affected genes in P10 homozygous Crx mutant retinas. a, b Gene expression (log2 CPM) in
the indicated homozygous mutants (y-axes) is compared with the WT control (C57BL/6 J, x-axes). Prototypical photoreceptor transcripts are labeled in
white. White diagonal lines represent ±2 FC. c, d Venn diagrams illustrate the numbers of significantly affected genes that are shared or are uniquely
changed in indicated mutants (FC ≥ 2 or ≤ -2, FDR ≤ 0.05)
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We also directly compared the data for overlapping and
independently affected genes in age-matched (P10) het-
erozygote and homozygote Crx mutant animals. Signifi-
cantly fewer down-regulated and up-regulated genes were
seen in the heterozygous E168d2/+ and R90W/+ mutants
than in their homozygous counterparts (Additional file 5).
Only a small fraction of genes was independently changed
in either heterozygote mutant but unaffected in the homo-
zygotes (Additional file 5). These data are consistent with
the differences in phenotype severity between the hetero-
zygous and homozygous mutants.
Crx mutations specifically affect rod- and cone-enriched
genes, including down-regulation of phototransduction
genes
To ensure that decreased retinal function and impaired
development of the Crx mutant mice are not a result of
perturbations to other non-photoreceptor cell types, we
analyzed the P10 RNA-seq data for changes in expression
of genes representing different types of retinal neurons.
For each cell type, we chose the ten genes with the highest
specificity ratio [27] present in our data. The heatmap in
Fig. 4a represents the FC from WT for each of these genes
in the P10 mutants, organized by the cell type they
represent. The cell types that showed the greatest gene
expression changes in all mutants were rod and cone pho-
toreceptors, whereas large-scale changes in gene expres-
sion were not observed in other retinal cell types at the
age of P10.
We also specifically analyzed expression of genes im-
portant for retinal visual function, as changes in this
pathway in cell types other than photoreceptors could
account for the decreased function as measured by ERG
[21]. Additional file 6 shows that non-photoreceptor-
specific genes encoding proteins involved in visual func-
tion had little to no change in expression in any of the
mutants. In contrast, expression changes were seen in
many known photoreceptor-enriched components of
Fig. 3 RNA-seq analyses detect graded changes in gene expression in P10 heterozygous Crx mutant retinas. a-c Gene expression (log2 CPM) in
the indicated heterozygotes (y-axes) are compared with the WT control (C57BL/6 J, x-axes). Prototypical photoreceptor transcripts are labeled in
white. White diagonal lines represent ±2 FC. d, e Venn diagrams illustrate the numbers of significantly affected genes that are shared or are
uniquely changed in the indicated mutants (FC ≥ 2 or ≤ -2, FDR ≤ 0.05). f, g Analysis of the union of genes affected in heterozygous mutants
(FC ≥ 2 or ≤ -2, FDR ≤ 0.05) presented as FC relative to WT control. Significance calculated by Wilcoxon rank-sum test with Bonferroni correction.
Notched box whisker plot describes median and quartiles of data
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the phototransduction cascade (Fig. 4b). Nearly every
constituent was negatively impacted in E168d2/+, but
remained virtually unaffected in R90W/+. E168d2neo/+
adopted an intermediate expression level, again empha-
sizing the stepwise and graded changes between the
three genotypes.
Insights from E168d2/+ and E168d2neo/+: small changes
in gene expression level strongly influence phenotype
Since the above analysis detected little difference be-
tween the two phenotypically distinct mouse lines that
both carry the same Crx mutation, E168d2/+ and
E168d2neo/+, we expanded our analyses to directly
Fig. 4 Crx mutant retinas show graded changes in photoreceptor-specific gene expression. a, b Heatmaps present FC of gene expression in P10
Crx mutants relative to that of WT age-matched controls in subsets of genes with highest cell type specificity ratios for the six retinal neurons (a)
and photoreceptor-enriched genes involved in phototransduction (b). c Changes in gene expression levels (log2 CPM) are compared for E168d2/
+ (x-axis) versus E168d2neo/+ (y-axis). Highlighted genes represent 118 transcripts significantly differently expressed between the mutants (FDR ≤
0.05, no FC cutoff; see Additional files 7 and 11 for designations). d, e Top Gene Ontology (GO) terms of down-regulated (d) and up-regulated (e)
gene sets in E168d2/+ compared with E168d2neo/+
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compare these two datasets. A scatterplot comparing
E168d2/+ and E168d2neo/+ shows only subtle expression
differences (Fig. 4c), further confirming the analyses
presented in Table 2 and Fig. 3. Differences in gene
expression levels were within the twofold margin with
only a few exceptions. To decipher the genes that are
likely to impact phenotype severity, we analyzed the 118
genes that passed the statistical threshold in the direct
comparison of E168d2/+ versus E168d2neo/+ (FDR
≤ 0.05, no FC cutoff, represented in white in Fig. 4c).
To confirm the validity of the results of this compari-
son, we also calculated the Z-score of each biological
replicate from the mean expression level (Additional
file 7), which showed reproducible differences between
the two genotypes. The list of down-regulated genes in
E168d2/+ was highly enriched for those relevant to
photoreceptor biology and function by Gene Ontology
(GO) analyses (Fig. 4d). In contrast, the up-regulated
genes showed only a modest enrichment for a single
photoreceptor-relevant GO category (Fig. 4e). These
findings suggest threshold effects of expression level
changes on photoreceptor phenotype, especially in
those pathways represented in the down-regulated gene
set illustrated in Fig. 4d.
Heterozygous mutants show normal gene expression
trends from P10 to P21, but many genes fail to reach the
normal level at P21
Crx mutant mice show early deficits in photoreceptor
morphology and function [18, 21]. In heterozygous Crx
knockout and R90W mice, morphology and function re-
cover at later ages, suggesting a transient developmental
delay. E168d2neo/+ mice also recover rod morphology
but have abnormal cone morphology and only partially
recover rod and cone function in adulthood. E168d2/+
mice remain impaired in adulthood with shortened outer
segments and severely impaired retinal function [21],
suggesting a blockade in photoreceptor maturation. To
determine if differences in morphological and functional
recovery are related to gene expression changes over
time, we also performed RNA-seq analyses on heterozy-
gous R90W, E168d2 and E168d2neo mutants at P21 when
photoreceptors are mature. The P21 gene expression data
described a very similar scenario seen in the P10 datasets:
The three heterozygous genotypes displayed a graded
degree and number of genes affected in the mutants rela-
tive to the P21 WT control (Table 1; Figure S6a–e in
Additional file 8).
Next, we compared expression changes in the hetero-
zygous mutants between P10 and P21 relative to P10
WT expression levels. In WT mice, 678 genes showed
expression changes between P10 and P21 (FC ≥ 2 or ≤
−2, FDR ≤ 0.5), as shown in a heatmap (Figure S7a in
Additional file 9). These age-dependent gene expression
changes likely reflect retina terminal differentiation: GO
analyses showed that the top 100 up-regulated genes were
enriched for those important for developing mature
photoreceptor structure and function, including visual
perception, detection of light stimulus, photoreceptor
outer segment formation and monovalent inorganic cation
transport (Figure S7b in Additional file 9). In contrast, the
down-regulated gene set was composed of genes that are
important for neurogenesis during development, including
system development, cell adhesion and regulation of cell
proliferation (Figure S7b in Additional file 9). We next
analyzed age-dependent gene expression changes in the
Crx mutant lines, primarily focusing on E168d2/+ and
E168d2neo/+ models, because of their distinct phenotype
from WT mice. Unexpectedly, both mutants showed a
trend of changes similar to WT mice for P21 up-regulated
and down-regulated gene sets (Figure S7a, c in Additional
file 9). In mutants, however, expression of many members
of these two gene sets did not reach the WT level at P21
(Figure S7a, c in Additional file 9). As expected, this defect
was more prominent in E168d2/+ than E168d2neo/+
mice. This suggests that the E168d2/+ mutants continue
to develop after P10 and recover some gene expression,
but the degree of recovery is insufficient to achieve nor-
mal photoreceptor maturation. Interestingly, R90W/+
also displayed slightly altered expression levels of many
dynamically changed genes. These subtle differences
may eventually contribute to the minor functional defi-
cits observed for R90W/+ at 6 months of age [21].
Taken together, these data suggest that Crx mutant mice
fail both in repressing developmental genes and in activat-
ing genes required for photoreceptor maturation. These
age-related gene expression changes support the morpho-
logical and functional observations that Crx mutant mice
vary in their photoreceptor maturation rates.
Down-regulated and up-regulated genes in Crx mutants
show distinct epigenetic profiles in WT retinas
To determine the modality of CRX’s regulation of differ-
entially expressed genes, we further investigated their
expression patterns and the epigenetic landscape of their
proximal cis-regulatory regions in WT mice. We first used
hierarchical cluster analysis on P10 and P21 datasets to
find sets of genes that were similarly affected in all
mutants. Figure 5a shows a heatmap representing log2 FC
relative to age-matched WT samples for any gene that
displayed significant change from WT (FC ≥ 2 or ≤ −2,
FDR ≤ 0.05) in any single genotype; the data are arranged
by hierarchical clustering (clustering branches are shown
to the left of the heatmap). By visual inspection of clus-
tered data, we further subdivided affected genes into eight
groups based on similarity of altered expression patterns.
These are designated as groups 1–8 (shown to the right of
the heatmap; see Additional files 10 and 11 for lists and
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order of genes). Further analyses focused on groups 1, 2, 3
and 6, as these represented the largest and most consistent
clusters. Visual inspection of biological replicate data also
confirmed the consistency of the expression changes in
these groups (Additional file 12). Group 1 genes were the
most down-regulated genes across all genotypes. Group 2
genes were decreased compared with WT levels, but
across the board were less affected than those in group 1.
Groups 3 and 6 were composed of genes that were up-
regulated in many of the genotypes. Group 6 genes gener-
ally were up-regulated to a greater extent.
The proximal cis-elements of down-regulated genes are
enriched for CRX and NRL binding
To determine which of the above four major gene
groups are directly regulated by CRX and its interacting
Fig. 5 Hierarchical clustering and epigenetic data reveal groups of similarly regulated genes. a Hierarchical clustering analysis of all genes that
showed significantly altered expression (FC ≥ 2 or ≤ −2, FDR ≤ 0.05) in at least one mutant genotype relative to age-matched WT expression.
Expression levels in the indicated genotypes at the indicated ages are indicated by the blue–red heatmap. Eight groups of genes (indicated by
the bars on the right) are clearly defined by the results (see Additional file 11 for designations). b Heatmaps showing the epigenetic landscape
near the transcription start site (TSS) of genes in groups 1, 2, 3, and 6. Each row represents ±1 kb from the TSS (at center of panel) of individual
genes contained within the groups as noted on the left; rows are ordered within each group by decreasing DNase I hypersensitivity (DHS) at the
TSS in the 8-week dataset. Columns 1–2, CRX binding determined by ChIP-seq in adult WT and Nrl−/− retinas, respectively; column 3, NRL ChIP-seq in
adult WT retinas; columns 4–6, DHS of WT retinas at three indicated ages; columns 7–8, H3K4me2 ChIP-seq in WT retinas at P1 and P15, columns 9–10,
H3K27me3 ChIP-seq in WT retinas at P1 and P15. Quantification is presented in Additional file 13
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rod-specific transcription factor NRL, we analyzed previ-
ously published CRX and NRL ChIP-seq data [15, 17]
obtained from adult mouse retinas for all of the genes in
these four clusters. Since CRX is expressed by both rods
and cones, CRX ChIP-seq data from both WT (predomin-
antly rod) and Nrl−/− (predominantly cone) retinas were
included in our analyses. The WT NRL ChIP-seq data
represent rod data, since NRL is not expressed in cones.
The data are presented in heatmaps in Fig. 5b (columns
1–3), where each gene within the group is represented by
a single line. The data within each column report the aver-
age read depth of the indicated experiment ±1 kb in 40 bp
bins centered on the transcription start site (TSS). These
results presented interesting contrasts between the various
groups of genes: First, groups 1 and 2 displayed a signifi-
cant amount of CRX binding in rods (column 1) and
cones (column 2) and NRL binding in rods (column 3)
around the TSS, while this binding was virtually absent in
groups 3 and 6 (Fig. 5b, columns 1–3; Figure S9a–c in
Additional file 13). This suggests that the down-regulated
genes in groups 1 and 2 are enriched for direct CRX/NRL
targets, but not the up-regulated genes in groups 3 and 6,
consistent with the primary role of CRX and NRL in
transactivation. Second, the more extensively down-
regulated genes in group 1 showed more CRX (columns 1
and 2) and NRL (column 3) binding than the less-severely
down-regulated genes in group 2 (Fig. 5b, columns 1–3;
Figure S9a–c in Additional file 13), raising the possibility
that group 1 genes are more dependent on CRX/NRL
transactivation activity than group 2 genes. Third, com-
parison of CRX binding in rods (column 1) versus cones
(column 2) for group 1 genes showed a high degree of
CRX binding in both photoreceptor subtypes, suggesting
that this group contains genes that are activated by
CRX in both rods and cones. In contrast, group 2 genes
showed CRX binding largely in rods, suggesting these
genes are activated by CRX mainly in rods (Figure S9a,
b in Additional file 13).
Down-regulated genes become more “open” during
postnatal retinal development
To determine which of the four major groups undergo
epigenetic landscape changes during photoreceptor devel-
opment, we analyzed three different sets of previously
published and publicly available epigenetic signature data
(Fig. 5b, columns 4–10). Results are presented as heat-
maps in a similar format as CRX and NRL ChIP-seq data.
We first analyzed retinal DNase I hypersensitivity
(DHS) datasets at the age of P1, P7 and 8 weeks (Fig. 5b,
columns 4–6) from the ENCODE project [22]. Enriched
DHS is an indicator of ‘open’ chromatin and is a pre-
dictor of active transcription. Both down-regulated and
up-regulated genes showed dynamic changes in their
epigenetic landscapes with age. First, group 1 genes
showed increases in DHS signal from P1 to 8 weeks of
age. This pattern is not seen in group 2 genes, in which
high DHS signal was largely stable across the ages
tested. Group 3 and 6 genes, on the other hand, showed
different patterns, in which DHS signal decreased from
P1 to 8 weeks of age. Second, comparing across groups
at 8 weeks of age, DHS data described groups 1 and 2
as having more ‘open’ chromatin (higher DHS signal)
around their TSS than groups 3 and 6 (Fig. 5b, column
6). These data suggest that the chromatin of genes
down-regulated in Crx mutants (groups 1 or 2) have
‘open’ chromatin in the adult WT retina and the most
strongly down-regulated genes (group 1) are genes that
develop a more ‘open’ chromatin conformation postna-
tally. In contrast, up-regulated genes (groups 3 and 6)
tended to have ‘open’ chromatin in the early postnatal
retina that became more ‘closed’ with age. To determine if
these dynamic DHS changes represented specific events
for particular groups, we included a random control group
in our analyses. A random set of genes was chosen from
the UCSC Table Browser ‘UCSC Genes’ list (see “Mate-
rials and methods”) to match the size of the largest group
from the analysis (“random” group). As illustrated by
Figure S9d–f in Additional file 13, the random group (grey
lines) also showed a trend of reduction in DHS during
postnatal retinal development. Importantly, when com-
pared with random group genes, group 1 genes were less
‘open’ at P1 and P7 (Figure S9d, e in Additional file 13,
blue line versus grey line) but more ‘open’ at 8 weeks
(Figure S9f in Additional file 13, blue line versus grey line),
verifying the trend visible by eye in the Fig. 5b heatmaps.
These results were consistent with the observation that
group 1 genes largely increased their expression from P2
to P21 during WT retinal development (Figure S9k in
Additional file 13, based on published RNA-seq data by
[24]). Interestingly, group 2 genes were more ‘open’ than
random group genes at all ages tested (Figure S9d,f in
Additional file 13, dashed blue line versus grey line),
consistent with an overall modest increase in their ex-
pression from P2 to P21 in WT mice (Figure S9l in
Additional file 13). In contrast, group 6 genes showed
overall lower DHS than random group genes at all
three ages analyzed, while group 3 genes showed simi-
lar DHS patterns as random group genes. Both group 3
and 6 genes normally showed no change or a slight
decrease in expression from P2 to P21 (Figure S9m, n
in Additional file 13). These data suggest the DHS
changes identified in group 1 genes are dynamically
regulated during retina development.
Down-regulated genes undergo histone modification
changes during postnatal retinal development
Next, we analyzed these gene groups for the presence
of active (H3K4me2; columns 7 and 8) and repressive
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(H3K27me3; columns 9 and 10) histone marks as deter-
mined by ChIP-seq in P1 and P15 WT retinas [23]
within the 2-kb window centered on the TSS of each
gene. Consistent with gaining a more ‘open’ chromatin
configuration, group 1 genes gained the active mark
H3K4me2 and lost the repressive mark H3K27me3 be-
tween P1 and P15 (Fig. 5b, columns 7–10; Figure S9g–j
in Additional file 13, blue line versus grey line). Group
2 genes showed similar changes in histone marks (in-
crease in H3K4me2 and decrease in H3K27me3) from
P1 to P15. Group 2 genes also showed a higher level of
the active mark H3K4me2 than random group genes at
P1, while the level of the repressive mark H3K27me3 was
similar to random at this age (Fig. 5b, columns 7–10;
Figure S9g–j in Additional file 13, dashed blue line versus
grey line). Overall, the data are consistent with a postnatal
constitutively open chromatin configuration for group 2
genes as measured by DHS. Finally, groups 3 and 6
showed no difference relative to the random group genes
in either H3K4me2 or H3K27me3 occupancy through ret-
ina development (Fig. 5b, columns 7–10; Figure S9g–j in
Additional file 13, red lines versus grey lines), consistent
with their overall constant low level of gene expression.
Together, the above analyses suggest that group 1 genes
undergo dynamic epigenetic changes during retina matur-
ation associated with their substantial transcriptional
activation during postnatal photoreceptor development.
The expression pattern of these genes correlated with CRX
and NRL expression, and their regulatory regions were
directly bound by CRX and NRL in WT mice. These re-
sults suggest that group 1 is enriched for genes that are
inactive in precursor cells and actively turned on by key
photoreceptor transcription factors during development.
Thus, mutations in CRX have a profound negative impact
on the expression of these genes. Group 2 genes were simi-
lar to group 1 in that their epigenetic landscape is support-
ive of high transcriptional levels in the WT retina and are
likely regulated directly by CRX and NRL. Interestingly,
these genes do not show the time-dependent chromatin
‘opening’, suggesting that CRX and NRL may not be neces-
sary to initiate chromatin remodeling and could account
for the fact that group 2 genes lose expression to a lesser
degree than group 1 genes. Finally, group 3 and 6 data
suggest that these genes undergo chromatin remodeling in
the WT retina that results in a less permissive state. This is
consistent with their low or even decreasing expression
over time. However, this process is not directly controlled
by CRX or NRL, as ChIP-seq binding of these two proteins
was not observed in these groups.
Up-regulated genes are characteristic of cone
photoreceptors, likely resulting from de-repression in rods
Since CRX and CRL binding as well as epigenetic data im-
plicate down-regulated genes as being active CRX targets
in rods, we investigated if differentially expressed genes
normally have rod or cone cell type-specific expression
patterns. Using published data [24] to classify these
genes as either rod- or cone-enriched (or non-specific),
we found a significant overrepresentation of rod genes
in groups 1 and 2, although a number of cone genes
were also found in group 1 (Fig. 6a; Additional file 10).
This was expected considering the mouse retina is rod-
dominant and CRX acts as a transcription activator for
genes critical for photoreceptor structure and function.
Surprisingly, however, up-regulated groups 3 and 6 con-
tained a significant enrichment of cone transcripts (Fig. 6a;
Additional file 10).
To determine whether this up-regulation of cone gene
expression is a general trend beyond group 3 and 6
genes, we expanded our analysis to all genes enriched in
either rods or cones in adult mice. Furthermore, to
ensure the results are applicable to other classes of Crx
mutants, we also analyzed three previously published
RNA-seq datasets from other Crx mutant models, Crx
−/−, Rip/+ and Rip/Rip. The results, presented as heat-
maps (Fig. 6b, c), showed a broad switch in the global
pattern of gene expression in all mutants, with loss of
expression of a large set of rod genes (Fig. 6b) and in-
creased expression of transcripts normally enriched in
cones (Fig. 6c). There were exceptions: expression of a
small number of cone genes (indicated with an asterisk at
the bottom of Fig. 6c) was consistently decreased in all the
Crx mutants. These represented key cone-specific photo-
transduction genes, including Pde6h, Arr3, Opn1mw,
Opn1sw, Gnat2, and others (Figure S10b in Additional file
14). Their loss of expression was similar to rod-specific
phototransduction components that also consistently de-
creased, including Rho, Gnat1, Cngb1, and Pde6g (Fig. 6b,
marked by asterisk; Figure S10a in Additional file 14).
Again, rod-enriched genes and cone-enriched genes dis-
played graded changes that reflected phenotype severity in
our models (most severe in E168d2/d2, least severe in
R90W/+). These results also place the Rip model (Rip/+
and Rip/Rip) in line with other Crx models, demonstrating
even more severe expression changes than E168d2/d2,
although the RIP protein is thought to cause disease by a
distinct molecular mechanism [24].
Because RNA-seq was performed on whole-retina
samples, the down-regulation of rod genes and up-
regulation of cone genes could represent a decrease in
the number of rods and an increase in cones. However,
previously published histology showed that, in fact, the
proportions of these cell populations shift in the oppos-
ite direction, as the E168d2/+ retina has a very severe
and early depletion of cone photoreceptors, prior to
any loss of rod photoreceptors [21]. In fact, all Crx mu-
tant mouse models, including Crx−/− and Rip/+, show
a similar trend of rapid cone loss followed by slower
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rod degeneration. This result was also unexpected con-
sidering the role of CRX in trans-activating cone as well
as rod genes [21, 28]. This raised the possibility that the
up-regulated cone genes were abnormally derepressed
in the mutant rods. To further understand the molecu-
lar mechanism underlying mis-expression of cone genes
in mutant rods, we assessed all rod- and cone-enriched
transcription factors for expression changes in the mu-
tants. Consistent with overall expression changes, we
observed a general loss of rod transcription factors and
enhanced expression of many cone-enriched transcrip-
tion factors (Figure S11a, b in Additional file 15).
However, the reduced expression of genes encoding
rod-specific factors essential for maintaining rod cell
fate, such as Nrl and Nr2e3, was rather minor or even
absent in the heterozygous E168d2 and R90W mutants,
unlike that reported for Rip mice [24]. Instead, these
results suggest an unexpected role for CRX in rods to
repress cone-enriched genes, including a number of
cone-enriched transcription factors. To test whether
CRX could play a direct role in repressing these cone-
enriched transcription factors, we examined the CRX
ChIP-seq data (Figure S11a–c in Additional file 15) for
evidence supporting a direct interaction of CRX with
Fig. 6 Crx mutants lose rod gene expression but up-regulate many phototransduction-unrelated cone gene transcripts. a Classification of genes
within groups 1, 2, 3, and 6 as rod-enriched (dark grey), cone-enriched (light grey), or not specific to a particular cell type (N.S., white) in the normal
adult retina. Rod and cone-enriched genes are defined based on the comparison of published P21 WT to Nrl−/− RNA-seq data [24]. Rod: FC ≥ 2,
FDR ≤ 0.05. Cone: FC ≤ -2, FDR ≤ 0.05. Fishers exact test, *p < 0.05, ***p < 0.0005. b, c Heatmaps depict hierarchical clustering of FC relative to
WT for all rod-enriched (b) and cone-enriched (c) genes. Expression data from a published RNA-seq study describing the Crx Rip/+, Rip/Rip, and
Crx−/− mice are also separately presented in the order determined by the aforementioned clustering. Regions noted in (b) and (c) with asterisks
are presented in larger format in Additional file 14 and represent many down-regulated genes involved in phototransduction in rods and cones.
d Immunohistochemical staining for RXRγ, CNGB3, and peanut agglutinin (PNA) in P10 WT and three Crx mutant retina sections. Scale bar = 100
μm. IS inner segment, ONL outer nuclear layer
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up-regulated cone transcription factors in rod cells. Some
up-regulated cone transcription factors showed low chro-
matin immunoprecipitation (ChIP) signal in WT retina,
suggesting a potential repressive binding in rods, but the
pattern was not consistent (Figure S11c in Additional file
15). Thus, loss of repression of cone genes in mutants is
likely a secondary effect. In contrast, ~33 % of rod genes
were bound by CRX, significantly enriched over random
genes (~8 %). Furthermore, when compared with NRL
ChIP-seq data, >73 % of CRX-bound rod genes were also
bound by NRL, but no enrichment of NRL binding was
observed for cone genes (data not shown), consistent with
CRX’s interaction with NRL to activate the expression of
rod genes, but not cone genes.
To verify that these cone transcripts are being de-
repressed in mutant photoreceptors that normally would
adopt a rod cell fate, we performed immunohistochemis-
try for several cone targets on retinal sections from three
E168d2 sublines and WT control mice at P10. The
nuclear receptor RXRγ (retionoid X receptor gamma) is
preferentially expressed by cones in P10 WT retina, and
is up-regulated in most Crx mutants by RNA-seq and
qRT-PCR [21] (Table S1a, b in Additional file 1; biological
replicate RNA-seq raw mapped sequencing reads dis-
played in Figure S2a, b in Additional file 4). As shown
in Fig. 6D (panels D1–D4), instead of the cone-
expression pattern in normal retina (Fig. 6d, panel D1),
RXRγ immunoreactivity was detected in most outer nu-
clear layer (ONL) cells of the homozygous and hetero-
zygous E168d2 mutant retinas (Fig. 6d, panels D2 and
D3), with a perinuclear distribution similar to the pat-
tern reported for rod transcription factors [8]. The
ONL RXRγ staining appeared stronger and more widely
spread in E168d2/d2 than E168d2/+ retinas. The
enhanced RXRγ immunoreactivity was not seen in
E168d2neo/+ ONL where the rods were not disturbed.
Immunostaining of the second cone marker, CNGB3 (cyc-
lic nucleotide gated channel beta 3), displayed similar pat-
terns of enhanced ONL expression in affected mutant
rods (Fig. 6d, panels D5–D8). We next assessed peanut
agglutinin (PNA) binding (Fig. 6d, panels D9–D12), which
normally stains the cone sheath including cone outer seg-
ments and pedicles. Figure 6d shows that, despite the lack
of cones and rod outer segments in E168d2/d2 retinas, a
strong and uniform PNA staining was seen across the
outer margin of the entire retina (Fig. 6d, panel D6), sug-
gesting that mutant rods adopt cone-like characteristics of
their sheath. E168d2neo/+ retinas did not show enhanced
PNA binding at this age (Fig. 6d, panel D12), while
E168d2/+ showed an intermediate PNA staining that was
higher than in WT but much lower than in E168d2/d2
retinas. Taken together, all three selected cone markers
showed enhanced expression in mutant rods in the order
E168d2/d2 > E168d2/+ > E168d2neo/+, thus confirming
RNA-seq findings of the impact of Crx mutations on rod
cell fate.
In summary, our RNA-seq analyses identified graded
expression changes of shared gene sets in seven available
mouse models for CRX-associated disease. Using the
data presented and referenced in this paper [2, 21, 24],
these models can be ranked as illustrated in Fig. 7, with
the lightest bars representing the model with most se-
verely affected rod and cone gene expression. This order
correlates with phenotype severity by morphological and
electrophysiological standards, and with changes in gene
expression in rods and cones. This correlation was seen
not only for down-regulated rod and cone genes encod-
ing phototransduction components, but also for those
Fig. 7 Model of how Crx mutation-caused gene expression changes affect rod and cone development. The left panel describes the formation of
cones in a subset of the Crx mutants and variable levels of those cells’ expression of phototransduction genes. The right panel shows how
development of rods in all models is related to their gene expression changes. It also emphasizes the novel findings that Crx mutant rods
display a graded phenotype of both the decreased expression of proper rod genes, and the mis-expression of cone genes
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up- and down-regulated gene sets that highlight the
partial rod to cone conversion of the developing photo-
receptors. The schematic also predicts the level of
photoreceptor identity and function in various models.
Most importantly, the different gene expression changes
between some phenotypically distinct Crx mutant models
(such as E168d2/+ versus E168d2neo/+) were rather mod-
est, in contrast to their substantial impact on the disease
phenotype.
Testing the effect of gene expression changes on light-
dependent degeneration
E168d2neo/+ but not E168d2/+ mice are sensitive to light
damage
To validate the phenotypic significance of the small dif-
ferences in gene expression between E168d2/+ and
E168d2neo/+ mice (Fig. 4c), we analyzed expression of
genes involved in the photoreceptor retinoid (visual)
cycle that is responsible for the recycling of visual
pigment chromophore 11-cis-retinal by RNA-seq (Fig. 8a;
Figure S2a, b in Additional file 4) and qRT-PCR (Table
S1c in Additional file 1). This discrete set of visual cycle
genes expressed in photoreceptors also showed a similar
pattern of expression changes across the mutant lines
(Fig. 8a): R90W/+ showed little or no changes relative to
WT, while E168d2/+ and E168d2neo/+ showed reduc-
tion in gene expression levels. We validated the expres-
sion patterns of three visual cycle genes, Rbp3, Rdh12
and Abca4, by qRT-PCR and results were consistent
with RNA-seq findings (Table S1c in Additional file 1).
We hypothesized that, as a result of these changes
combined with slight shifts in expression levels of photo-
transduction genes (Fig. 4b), the two E168d2 sublines
may have different sensitivity to light-induced damage
(LD). Exposing mice to high intensity light for an
extended period of time puts stress on the retina and
can lead to photoreceptor degeneration [29]. LD-related
degeneration depends on three interconnected pathways
(Fig. 8b): 1) the phototransduction pathway, 2) the visual
cycle in the retinal pigment epithelium (RPE) and 3) the
visual cycle in photoreceptor cells. Most mouse models
with disruptions to components of phototransduction
are insensitive to LD [30], while mice with an impaired
visual cycle in photoreceptors generally have increased
sensitivity to LD [31–35]. To test if the transcriptional
defects in E168d2/+ and E168d2neo/+ mice alter their
sensitivity to LD, we exposed 6-week-old WT, E168d2/+
and E168d2neo/+ mice to a high intensity light [12–13.5
kilolux (KLUX); ~10–20 times brighter than ambient
light conditions] for 8 h. Following LD exposure, mice
were kept in a 12 h ambient light/dark cycle for 7 days
before retinal function and morphology were assessed.
All the mice tested were backcrossed to the C57BL/6 J
background for more than ten generations, which is
resistant to LD [36]. As expected, WT mice were highly
resistant to LD and displayed normal retinal morphology
(Fig. 8d versus Fig. 8c, left panels), normal ONL thick-
ness as determined by morphometry (Fig. 8e, left panel),
and normal retinal function as measured by ERG (Figure
S12a in Additional file 16, black dashed lines versus
black solid lines) compared with WT controls that were
not exposed to LD. E168d2/+ mice exposed to LD did
not show differences in retinal morphology (Fig. 8d ver-
sus Fig. 8c, middle panels) or ONL thickness (Fig. 8e,
middle panel) and showed only minor ERG differences
compared with normal light-exposed E168d2/+ controls
(Figure S12a in Additional file 16, red dashed lines
versus red solid lines). In contrast, E168d2neo/+ mice
exposed to LD showed shortened outer segments and a
loss of ONL nuclei, ~3–4 nuclei compared with ~10–12
nuclei in normal light E168d2neo/+ mice (Fig. 8d versus
Fig. 8c, right panels). Morphometry revealed significant
reduction in ONL thickness at the inferior −100 μm and
superior 100 μm and 500 μm positions, with the thick-
ness at 500 μm being most affected (~58 % reduced;
Fig. 8e, right panel). Retinal function was also affected
with dark-adapted a-waves, dark-adapted b-waves and
light-adapted b-waves all showing reduced maximal re-
sponse amplitudes compared with E168d2neo/+ controls
kept in normal light (Figure S12a in Additional file 16,
blue dashed lines versus blue solid lines). These data
suggest that E168d2neo/+ mice are more susceptible to
LD than either E168d2/+ or WT mice, providing further
insight into the distinct pathobiology of E168d2/+ and
E168d2neo/+ mice.
E168d2neo/+ sensitivity to light damage is linked to
abnormal visual cycle in photoreceptors
To determine if the increased sensitivity to LD in
E168d2neo/+ mice reflects changes in expression of visual
cycle genes, mice were pre-treated with 13-cis retinoic
acid (13-cis-RA; isotretinoin) before LD exposure. 13-cis-
RA interferes with the regeneration of visual chromo-
phore (11-cis-retinal) and is a strong antagonist of the
RPE-driven phase of the visual cycle [37]. Inhibiting the
visual cycle at the earliest stage reduces the production
of toxic retinoid intermediates in the retinoid pathway
during LD (Fig. 8b). This treatment strategy was previ-
ously shown to effectively ameliorate retinal degener-
ation in mouse models with impaired visual cycle [34,
35, 37]. Retinas of WT mice pretreated with 13-cis-RA
and exposed to LD were morphologically indistinguish-
able from dimethyl sulfoxide (DMSO)-injected controls
(Fig. 8f, two left panels). In contrast, retinas of E168d2neo/
+ animals pretreated with 13-cis-RA were almost com-
pletely protected from the rapid degeneration observed in
DMSO-injected E168d2neo/+ controls (Fig. 8f, two right
panels). Retinas of 13-cis RA-pretreated E168d2neo/+
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Fig. 8 (See legend on next page.)
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mice revealed significant improvements in ONL thick-
ness at the superior 500 μm and 1000 μm positions
(Fig. 8g, right panel) compared with those that were
DMSO treated. Retinal function was also better pre-
served in 13-cis-RA pretreated mice. Amplitudes of
dark-adapted ERG a-wave, dark-adapted b-wave and
light-adapted b-wave were all significantly restored in
13-cis-RA pretreated E168d2neo/+ mice compared with
DMSO-injected controls (Figure S12b in Additional file
16, green lines versus blue dashed lines). To validate
that LD sensitivity is linked to intrinsic defects in the
visual (retinoid) pathway, we tested rod dark adaptation
in WT and E168d2neo/+ mice. Following >90 % rhod-
opsin photobleach, the dark adaptation of E168d2neo/+
mouse rods was substantially delayed compared with
that in WT mice (Figure S12c in Additional file 16, blue
line versus black line). Pretreatment of E168d2neo/+
mice with 13-cis-RA strongly delayed rod dark adapta-
tion further (Figure S12c in Additional file 16, red line
versus blue line), indicating that 13-cis-RA effectively
blocked regeneration of visual pigment by the RPE vis-
ual cycle. Together, these data suggest that the in-
creased sensitivity of E168d2neo/+ mouse retinas to LD
is linked to intrinsic defects in the photoreceptor visual
cycle.
Finally, to determine if the degeneration of photore-
ceptors in E168d2/+ mice is at all affected by ambient
light conditions, we reared E168d2/+ mice under either
a normal 12 h light/dark cycle or in constant darkness.
Retinal morphology of E1682/+ mice raised under either
light condition was indistinguishable at 3 and 6 months
of age (Additional file 17), suggesting that photoreceptor
degeneration in E168d2/+ mice is independent of light
conditions. These results illustrate that photoreceptor
degeneration in E168d2/+ and E168d2neo/+ mice is me-
diated by discrete light-independent and light-dependent
mechanisms, respectively.
Discussion
Gene expression in animal models for CRX-associated
retinopathies
Our RNA-seq results for mutant Crx E168d2 and R90W
mouse retinas improve and expand upon previously
published genomic expression microarray studies and
qRT-PCR on these mouse lines [21]. The increased sen-
sitivity of this platform allowed for the detection of more
differentially expressed genes, especially for genes with
low expression level, and also for the detailed analysis of
the modest expression level differences between hetero-
zygous animals. In combination with RNA-seq data from
Crx−/− and Rip mice [24], a comprehensive dataset of
retinal gene expression now exists for Crx mutant
models with a range of phenotypes that reflect human
disease. We have used these datasets to identify key
changes in gene expression that correlate with disease
severity.
Our results suggest that even relatively small changes
in gene expression level can have a profound effect on
the delicate balance of cellular pathways critical for
photoreceptor function and survival, especially photo-
transduction and the visual cycle. Our RNA-seq analysis
of retinal gene expression in mutant Crx mouse models
by several methods indicates graded changes in photo-
receptor gene expression at every level from overall
expression patterns down to specific cellular pathways.
First, homozygous mice were always more severely af-
fected than their heterozygous counterparts (Additional
file 5). Among homozygous and heterozygous mice, ex-
pression changes from least to most severe consistently
followed the pattern R90W < E168d2neo < E168d2.
These patterns were observed for both down-regulated
and up-regulated genes. A high degree of overlap existed
in the differentially expressed genes among models
(Figs. 2 and 3; Additional file 8) and few genes displayed
opposite expression patterns between models (Fig. 5).
(See figure on previous page.)
Fig. 8 Light-dependent photoreceptor degeneration in E168d2neo/+ mice. a Heatmap presents P21 Crx mutant FC relative to WT for genes
involved in the photoreceptor visual cycle. b Model for the RPE visual cycle: visual chromophore [11-cis-retinal (RAL)] is generated in the retinal
pigmented epithelium (RPE) and delivered to the photoreceptor; stimulation of 11-cis RAL bound to an opsin protein activates the
phototransduction cascade leading to photoreceptor membrane hyperpolarization; this process isomerizes 11-cis RAL into all-trans RAL, which is
then recycled back into 11-cis-RAL through a series of enzymatic steps, known as the visual cycle, in the photoreceptor and RPE. The drug 13-cis
retinoic acid (13-cis-RA) blocks the synthesis of 11-cis-RAL, effectively reducing the burden on the retinoid cycle. ROL retinol. c, d Retinal
morphology of 6-week-old mice with indicated genotypes under normal light conditions: 12 h room light–dark cycle (c) or light damage (LD)
treatments (8 h 11.5–13.5 KLUX bright light followed by 7 days of normal light–dark cycles) (d). Retinal morphology was assessed by hematoxylin
and eosin (H&E) staining of sagittal retinal sections through the optic nerve (ON). Images were taken in the central superior retina (~500 μm from
the ON). e Morphometry quantification of ONL thickness for the samples presented in (c, d). Error bars represent standard error of mean (SE)
from three or more biological replicates and significance was calculated using two-way ANOVA. Data points that significantly differ from the
control (p ≤ 0.05) are marked by red asterisks. f, g Effect of 13-cis retinoic acid (13-cis-RA) pretreatment on LD in E168d2neo/+ mutant mice:
retinal morphology (f) and morphometry (g) at 7 days following LD where mice were pretreated with 13-cis-RA or dimethyl sulfoxide (DMSO)
as control. Note the significant improvements in ONL thickness and photoreceptor outer segment (OS) length in the mice treated with 13-cis-
RA. GCL ganglion cell layer, INL inner nuclear layer, IPL inner plexiform layer, ONL outer nuclear layer, OPL outer plexiform layer, OS outer seg-
ment. Scale bar = 50 μm
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This suggests that few unique gene targets exist be-
tween models, and non-overlapping genes largely result
from genes with similar trends in expression that sim-
ply do not pass the significance threshold of the in
silico analysis. Graded changes were also observed for
genes involved in retinal development; Crx mutants
showed impairment in both the activation and repres-
sion of genes that shift expression patterns from P10–
P21 (Additional file 9). Despite having collected mRNA
from the whole retina, we were able to determine that
the differentially expressed genes mostly occurred in
rod and cone photoreceptors by using known patterns of
cell type-specific retinal gene expression (Fig. 4a). This
was consistent with CRX’s expression pattern and role in
photoreceptor maturation. Within photoreceptor-specific
pathways involved in light response, namely rod and cone
phototransduction and the visual cycle, all Crx mutant
models displayed graded down-regulation (Figs. 4b and
8a). Aside from these pathways, down-regulated genes
tended to be rod genes, while up-regulated genes tended
to be cone genes de-repressed in rods (Fig. 6; Additional
file 15). We investigated genes that did not fall into either
category (Additional file 10) but did not find any other
major trends beyond this. Expansion of this analysis by
assessing expression of all known rod or cone-enriched
genes again showed a graded pattern of expression
changes in these genes (Fig. 6b, c), including rod and
cone-specific transcription factors (Figure S11a, b in Add-
itional file 15). Re-analysis of previously published micro-
array data [21] showed the same trends of gene expression
changes (data not shown). Finally, by analyzing RNA-seq
results from two previously published animal models, Crx
−/− and Rip, we were similarly able to detect graded ex-
pression changes in a common gene set (Fig. 6). In all, our
analyses show graded changes in gene expression at sev-
eral levels in Crx mutant mice for both down-regulated
and up-regulated genes.
Different modalities for down-regulated and up-regulated
gene expression
While Crx mutant mice showed both down-regulated
and up-regulated expression (Table 2), more genes were
down-regulated in every mouse model tested. This is
consistent with CRX’s established role as a transcrip-
tional activator, though CRX does act as a repressor in
certain contexts [38]. Utilizing available CRX [15] and
NRL ChIP-seq [17] data sets and epigenetic data sets
including DHS from the ENCODE project [22] and
active (H3K4me2) and repressive (H3K27me3) histone
marks [23], we identified patterns in the proximal cis-
regulatory elements of differentially expressed genes.
CRX and NRL binding were enriched at genes that
were down-regulated in Crx mutant models, suggesting
these genes are direct targets, while genes that were
up-regulated were not enriched for CRX or NRL bind-
ing, suggesting these genes are indirect targets (Fig. 5).
DHS data showed that a group of strongly down-
regulated genes in mutant models shifted from ‘closed’
to ‘open’ chromatin from P1 to 8 weeks old in WT
rods, suggesting these genes are normally activated dur-
ing postnatal retinal development (Fig. 5; Figure S9d–f
in Additional file 13). In contrast, the data described
that a group of up-regulated genes became more
‘closed’, suggesting these genes are being repressed dur-
ing postnatal development (Fig. 5b; Figure S9d–f in
Additional file 13). The group of down-regulated genes
also showed an increase in the active histone mark
H3K4me2 and a decrease in H3K27me3 during postna-
tal development in WT retina (Fig. 5b; Figure S9g–j in
Additional file 13), indicative of active chromatin re-
modeling. Changes in these histone marks were not
observed for up-regulated genes, suggesting these genes
are not subject to this type of active chromatin remod-
eling. Together, these results suggest that genes down-
regulated in Crx mutant models are direct targets of
CRX and NRL that normally are activated during post-
natal development through chromatin remodeling,
while up-regulated genes are indirect targets of CRX
and NRL that are normally repressed during postnatal
development through an unknown mechanism. CRX is
known to recruit co-activators with positive chromatin re-
modeling capacity, such as CBP/p300 and the STAGA
complex [39, 40]. Thus, CRX and its interacting co-
activators may play an essential role in active chromatin
remodeling during development for the direct target genes
represented by the down-regulated groups in Crx mu-
tants. Future profiling of epigenetic changes in these Crx
mutant models will provide additional support for this
possibility.
Crx mutations affect rod and cone development and
transcriptional integrity
The graded expression changes in Crx mutant models
have profound effects on the development of their rods
and cones as illustrated in Fig. 7. Homozygous Crx−/−,
E168d2, R90W, Rip and Rip/+ mice do not form physio-
logically functional photoreceptors due to a strong re-
duction in both rod and cone phototransduction gene
expression. Other models show gradations in both ret-
inal function and phototransduction gene expression. In
all models studied, the development and survival of
cones are affected earlier and more severely than rods,
implicating CRX in the terminal differentiation of cones.
Interestingly, in WT rods, CRX and NRL appear to me-
diate both the activation of rod-specific genes and the
repression of cone-specific genes. The dual reduction in
rod-gene expression and de-repression of cone genes in
Crx mutant rods coincides with rods adapting more
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cone-like properties, including less condensed chromatin
and shorter outer segments [21, 24]. In Rip/+ mice, this
shift was found to coincide with loss of NRL expression
by P21, indicating a complete loss of rod cellular iden-
tity. The loss of NRL expression does not occur in
E168d2/+ mice by this age, but de-repression of cone
genes in rods is still observed. While E168d2 protein
does not affect the function of NRL in vitro [21], its
effect on NRL in vivo is uncharacterized. Our results
provide evidence that even though RIP and E168d2
mutant proteins act through different pathological
mechanisms, the resulting pathologies arise from scaled
changes in similar sets of genes.
Gene expression dictates phenotypic thresholds
The animal models used in this study have wide-ranging
phenotypes that match those observed in human pa-
tients. The magnitude of overall gene expression changes
correlated with phenotype severity in every model tested,
but not in a linear manner. Instead, there are thresholds
in gene expression that determine phenotypic presenta-
tion. An example of this threshold effect is evident in
the E168d2/+ and E168d2neo/+ mice. These mice have
drastically different phenotypes but have only small
differences in gene expression. As we have previously
shown, the neomycin cassette retained in E168d2neo/+
mice suppresses an accumulation of the mutant tran-
script by an unknown mechanism [21]. qRT-PCR results
(Table S1a in Additional file 1) of the same biological
samples used for RNA-seq confirm that the WT allele
showed no compensation and maintained approximately
50 % of its normal expression. In contrast, the results of
RNA-seq (Additional file 18) and qRT-PCR (Tables S1a,
b in Additional file 1), combined with previously pub-
lished western blots and immunohistochemistry [21], all
support a significant overexpression of mutant Crx mRNA
and protein in E168d2/+ mice. This mutant allele-specific
overexpression was not evident in E168d2neo/+ mutants.
This difference in expression of the dominant negative
form of CRX resulted in very small difference in FC of
down-regulated genes (median of −1.8 in E168d2/+ com-
pared with −1.7 in E168d2neo/+ mice; Fig. 3f, g). Despite
this slight difference, E168d2/+ mice had much more
severe deficits in retinal function and photoreceptor de-
generation. Under normal light conditions, E168d2neo/+
mice had little photoreceptor degeneration in early adult-
hood. However, E168d2neo/+ rods were highly sensitive to
light damage while WT and E168d2/+ rods were largely
resistant (Fig. 8). Targeting the visual cycle blocked sensi-
tivity of E168d2neo/+ photoreceptors to LD, implicating
this pathway in the degeneration phenotype. In contrast,
the degeneration of E168d2/+ photoreceptors was inde-
pendent of light and the visual cycle. Sensitivity to LD
requires phototransduction and is mediated by the visual
cycle, both of which are affected in the E168d2 and
E168d2neo mouse models. However, these results suggest
that the balance in function between these two pathways
could be critical for determining sensitivity to damaging
light. Our data support the conclusion that phototrans-
duction is too impaired and outer segment structural
changes are already too severe in E168d2/+ mice to allow
for further light-mediated degeneration, while E168d2neo/
+ photoreceptors largely preserve their structure and sub-
stantial levels of phototransduction components to reveal
visual cycle defects under intense light. These results high-
light that even minor tuning differences in photoreceptor
gene expression have a dramatic effect on the mechanisms
of disease pathology. These findings could have significant
clinical importance as patients with CRX-associated reti-
nopathies might have different responses to environmen-
tal factors like damaging light levels, which would affect
their clinical outcome. These results also provide clues for
potential therapeutic intervention to target the visual cycle
in patients with late-onset CRX-associated retinopathy.
Conclusions
Linking genotype to phenotype for CRX retinopathies re-
mains imprecise [41]. Genomic assessment of retinal gene
expression suggests that the range of phenotypes of Crx
mutant mouse models are driven by graded changes in
photoreceptor gene expression. Since CRX has such wide-
ranging function in photoreceptor transcription, muta-
tions that sometimes just slightly alter the expression of
many genes can have a profound effect on the resultant
phenotype. We relate retinal gene expression to pheno-
typic thresholds in rod and cone photoreceptor develop-
ment, cellular integrity, function and degeneration in
several Crx mutant mouse models. We have utilized
publicly available genomic datasets to gain insight into
cell type-specific expression changes and the different
modalities for gene down-regulation and up-regulation
in these mice. We have demonstrated how slight differ-
ences in gene expression can alter retinal susceptibility
to light-dependent degeneration in E168d2/+ and
E168d2neo/+ mice. These findings provide evidence
that CRX retinopathies stem from graded changes in
photoreceptor gene expression, which could signifi-
cantly contribute to phenotypic variability.
Materials and methods
Mice
Mice were housed in a barrier facility operated and
maintained by the Division of Comparative Medicine of
Washington University School of Medicine. All mice
used in this study were backcrossed to C57BL6/J mice
obtained from Jackson Laboratories (Bar Harbor, ME,
stock number 000664) for at least ten generations. Each
line was genotyped for common rd1, rd8, and Rpe65
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variants that affect retinal structure and function; all
lines were negative for rd1 and rd8 and contain the
C57BL/6 J RPE65450M isoform. The Crx mutant lines
E168d2, E168d2neo and R90W and their genotyping
procedures were published previously [21].
All procedures involving mice were approved by the
Animal Studies Committee of Washington University in
St Louis (IACUC 20120246, expiration date 18 January
2016). Experiments were carried out in strict accordance
with recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of
Health (Bethesda, MD, USA), the Washington University
Policy on the Use of Animals in Research; and the
Guidelines for the Use of Animals in Visual Research of
the Association for Research in Ophthalmology and
Visual Science [41].
RNA collection and library preparation
For each genotype and time point: three biological repli-
cates were analyzed, and each replicate consists of four
retinas from one male and one female mouse. P21 WT
samples represent a randomized sampling of WT litter-
mates of Crx mutants. Retinas were immediately proc-
essed for RNA using the PerfectPure RNA tissue kit (5
Prime). The quantity and quality of the RNA was assayed
using a Bioanalyzer (Agilent). Samples with a minimum
RNA integrity number (RIN) score of 8.0 were then se-
lected for library construction. Library construction was
performed by the Genome Technology Access Center
(Washington University in St Louis). mRNA was isolated
by poly(A) selection using Oligo-dT beads (mRNA Direct
Kit, Ambion) and then fragmented by incubation at 94 °C
for 2.5 min in an alkaline buffer (40 mM Tris acetate
pH 8.2, 100 mM potassium acetate, 30 mM magnesium
acetate) and reverse transcribed using Super Script III
enzyme (Invitrogen) and random hexamers to yield
double-stranded cDNA. The cDNA was blunt ended
using Klenow DNA polymerase, followed by addition of
an A base and ligation of Illumina sequencing adapters
to the 3’ ends. All enzymes, including DNA polymerase,
Klenow DNA polymerase, Klenow exo-, RnaseH, T4
DNA polymerase, and T4 polynucleotide kinase were
purchased from New England BioLabs. Ligated fragments
were amplified for 12 cycles using primers incorporating
the unique index tags before being sequenced on the Illu-
mina Hi-Seq 2000 using single reads extending 42 bases.
RNA sequencing data analysis
We aligned 1 × 42 bp reads to the mouse genome (version
mm9) with the sequence aligner TopHat2 (v.2.0.5) [42]
using the following parameters: −a 5 -m 1 -i 10 -I 500000
-r 100 –p 4 –microexon-search –no-coverage-search -x
20 –segment-length 25. Dependencies included Bowtie
(v.0.12.8) [43] and Samtools (v.0.1.18) [44]. Bedgraph files
were generated using BEDTools (v.2.23.0) [45] and visual-
ized using IGV. The HTSeq package (v.0.6.1p1) [46] was
used to assign aligned reads to the gene annotation refer-
ence track (UCSC Genes Track, UCSC Table Browser,
NCBI37/mm9, accessed 16 July 2014). This generated a
raw read count per gene which was used in EdgeR [26] for
detecting differentially expressed genes. For each of the
genotype comparisons, genes that did not pass the filter
criteria of CPM ≥ 5 in all replicates of at least one com-
parison group were removed prior to the analysis. Filtered
count data were normalized by the EdgeR default
normalization method, TMM, and differential expression
analysis for each of the comparison groups was performed
by the exact test. P values were subjected to Bonferroni
and Hochberg multiple testing correction to include FDR.
Downstream analysis was performed using custom Perl
and R scripts. PCA was performed using the princomp
function in the stats R package (v.3.1.1) [47]. Gene expres-
sion heatmaps were generated using the heatmap.2 func-
tion of the gplots R package (v.2.16.0) [48]. As several
heatmaps include too many genes to properly label each
row, we have listed the genes included in each heatmap in
the order in which they were presented in Additional file
11.
Raw RNA-seq data were also obtained from previously
published work: Gene Expression Omnibus (GEO) acces-
sion [GEO:GSE52006] [24]. These data were aligned also
using TopHat and analyzed as described above using
HTSeq and EdgeR.
Epigenetic data analysis
Data were obtained from GEO under accession num-
bers [GEO:GSE20012] [15], [GEO:GSE38500] [23], and
[GEO:GSM1014198, GSM1014175, GSM1014188] [22].
NRL ChIP seq [17] was downloaded from the NEI Data
Share website, accessible through [49]. Data were ana-
lyzed based on the mouse reference genome (NCBI37/
mm9) and UCSC known gene table. Heatmaps and line
graphs depicting epigenetic data were generated using
the UCSC defined TSS for each gene and the UNIX
software package HOMER (v.4.7) [50]. Heatmaps were
generated by importing the HOMER generated counts
back into R, ordering by adult DNase 1 level at the
TSS, and visualized by the heatmap.2 function in the
gplots R package.
GO analysis
GO analysis [51] was performed using the online g:Profiler
tool [52]. Terms were filtered to only include the best per
parent term.
LD and 13-cis-RA treatment
For LD analysis, mutant mice and littermate controls
were dark adapted overnight. Eyes were dilated with 1 %
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cyclogyl and 2.5 % phenylephrine hydrochloride. Mice
were then placed in darkness for 30 min before LD. LD
was performed in a temperature-controlled rat cage with
the top removed and lined with reflective material to pro-
vide even illumination. Exposure was performed using
white fluorescent light and the intensity was measured
using a lux meter. Light intensity was 11–13.5 KLUX in
all experiments. Mice were placed into cages containing
moistened food pellets, and each animal received dam-
aging light for 8 h. Mouse pupils were re-dilated and the
cage position was rotated every 2 h.
For 13-cis-RA treatments, 13-cis-RA (isotretinoin;
Sigma-Aldrich, R3255) was reconstituted in DMSO to a
concentration of 0.013 mg/μl. 13-cis-RA (40 mg/kg) or an
equal volume of DMSO vehicle control was injected into
the mouse's interperitoneal cavity 12 h before LD and
mice were dark-adapted overnight. Mice were re-dosed
with 40 mg/kg 13-cis-RA 30 min before LD.
Following all LD experiments, mice were returned to a
12 h light–dark cycle under normal ambient light condi-
tions (~100 LUX) for 7 days. After 7 days, retinal function
was tested by ERG. The peak amplitude responses for
rod-driven dark-adapted a-waves, rod ON bipolar cell-
driven dark-adapted b-waves and cone bipolar cell-driven
light-adapted b-waves were measured for a series of
increasing light intensities as described below. Mice were
then sacrificed and eyes were collected for retinal hist-
ology assessment (see below). Images were taken in the
central superior retina (~500 μm from the optic nerve),
which is the area of the retina that is most strongly
affected by LD [53].
Histology, immunohistochemistry and microscopy
Histology analyses of hemotoxylin and eosin (H&E)-
stained paraffin-embedded retinal sections were per-
formed as described previously [21]. For ONL morphom-
etry, 20× composites of whole retinal sagittal sections
stained with H&E were analyzed using ImageJ software
[54]. The distance from the optic nerve was determined
by drawing a curved line along the outer limiting mem-
brane. The ONL thickness was measured at 100 μm, 500
μm, 1000 μm, and 1500 μm from the optic nerve and 200
μm from the peripheral edge on both the superior and
inferior retina. Results are presented by a ‘spider graph’.
The between-group differences in ONL thickness were
determined by testing overall genotype–distance inter-
actions (p < 0.05, n ≥ 3) of each treatment. Statistical
comparison of data at each distance was performed
using two-way ANOVA for repeated measurement data,
followed by a post hoc test to adjust p value for multiple
comparisons between each genotype and the WT control
group SAS 9.3 (SAS Institutes, Cary, NC, USA).
Fluorescence immunohistochemistry was performed on
frozen retinal sections. Eyes were enucleated and fixed for
30 min in 4 % paraformaldehyde on ice. Eyes were washed
in phosphate-buffered saline (PBS) and left overnight in
30 % sucrose in PBS at 4 °C. A 50 % volume of O.C.T.
(Tissue-Tek, optimum cutting temperature formulation)
was added and rocked at room temperature for 1 h. Eyes
were then transferred to 100 % OCT for 1 h before frozen
in OCT on dry ice. Blocks were cut onto polylysine
(Thermo Scientific) slides and stored at −80 °C. For stain-
ing, slides were removed and allowed to dry for 30 min
before 10 min 4 % paraformaldehyde fixation. Slides were
washed (2 × 5 min) with PBS and blocked at room
temperature with 5 % nonfat dry milk/2 % bovine serum
albumin (BSA)/10 % normal goat serum for 2 h. Slides
were washed (3 × 5 min) with PBS before overnight incu-
bation with primary antibody at 4 °C. Antibodies were
diluted as below in PBS with 1 % BSA and 0.5 % Triton X-
100. Slides were washed (3 × 5 min) in PBS. Secondary
antibodies (and PNA antibody) were diluted in the
same buffer as primaries, applied to the slides, and in-
cubated for 1 h at room temperature, and washed again
(3 × 5 min) with PBS before the application of
coverslip.
Primary antibodies and dilutions used are as follows:
rabbit anti-RXRγ (1:500, Santa Cruz Biotechnology, sc-
555), rabbit anti-CNGB3 (1:500, from Xi-Qin Ding,
University of Oklahoma), PNA conjugated to rhodamine
(1:500, Vector Labs). Secondary antibodies (1:400) were
goat anti-rabbit or mouse IgG antibodies coupled to Alexa
Fluor A488 and rhodamine 568 (Invitrogen). All slides
were counterstained with hard-set mounting medium
with DAPI (Vectashield).
Brightfield and fluorescent imaging was performed using
either an Olympus BX51 microscope and Spot RT3
Cooled Color Digital camera (Diagnostic instruments Inc.)
or a Leica DM5500B microscope and Leica DFC365FX
camera (Leica Microsystems, Buffalo Grove, IL).
Electroretinography
Mice were dark-adapted overnight and anesthetized with
intraperitoneal injection of a mixture of ketamine (80 mg/
kg) and xylazine (15 mg/kg). Pupils were dilated with 1 %
atropine sulfate. A passive-heating pad maintained ani-
mal’s body temperature at 37 °C. Scotopic ERG responses
were measured from both eyes using corneal platinum-
ring electrodes held in place by a drop of Gonak solution.
Full-field ERGs were recorded with the UTAS-E 3000 sys-
tem (LKC Technologies, Inc.), using Ganzfeld-derived test
stimuli of calibrated white light intensity. The amplitude
of ERG a-wave was determined from the baseline to the
primary negative peak of the photoresponse. The ampli-
tude of ERG b-wave was measured from the a-wave peak
to the maximum of the secondary positive peak. Photopic
ERG recordings were performed under room illumination
(~25 cd · s m−2) after 5–10 min of light adaptation.
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The rate of rod dark adaptation was determined from
the recovery of maximal ERG a-wave amplitude after a
30-s exposure to light bleaching of >90 % of rhodopsin
(delivered by 520 nm LEDs focused at the surface of
mouse eye cornea and producing ~2.5 × 108 photons
μm−2 s−1), using test flashes of ~ 470 cd · s m−2 at indi-
cated times after the bleach. In these experiments, mice
were re-anesthetized subcutaneously every 30–40 min
with a smaller dose of ketamine (~50 % of the initial
dose). In addition, at the same time a drop of 1 % atro-
pine sulfate was added to the eye surface to keep pupils
dilated, and a 1:1 mixture of PBS and Gonak solutions
was applied to the eyes to protect them from drying and
maintain electrode contacts during extended recording
sessions.
Quantitative RT-PCR
RNA used for assays included RNA used for Illumina
RNAseq library preparation and additional biological
replicates. For each genotype, n ≥ 3 biological replicates,
each replicate consisting of four retinas from one male
and one female mouse, were collected. RNA isolation,
cDNA preparation, and qRT-PCR reactions were per-
formed as previously described [21]. Briefly, retina tissue
was immediately processed for RNA using the Perfect-
Pure RNA tissue kit (5 Prime) and quantified. cDNA
was synthesized from 1 μg of RNA using the Transcrip-
tor First Strand cDNA Synthesis kit (Roche Applied
Science). A 10 μl qRT-PCR reaction mixture containing
1× EvaGreen with Low Rox reaction mix (BioRad), 1 μM
primer mix, and diluted cDNA was prepared and run on
a BioRad CFX thermocycler in triplicate. Data were ana-
lyzed using QBase software (Biogazelle). Relative gene
expression was normalized to Ubb and Tuba1b and FC
from WT was determined. Kruskal-Wallis and Dunn's
multiple comparison tests were used to determine signifi-
cant FC differences from WT (p < 0.05). Primer sets were
designed using MacVector software and synthesized by
IDT DNA technologies (Additional file 19).
Data availability
Raw RNA seq data and primary analysis are available
from GEO under accession [GEO:GSE65506].
Additional files
Additional file 1: Table S1. Compiled comparison of RNAseq with new
and previously published qPCR data. (XLSX 14 kb)
Additional file 2: Table S2. Compiled list of read number for each
library. (XLSX 47 kb)
Additional file 3: Figure S1. P10 and P21 biological replicates
clustered by principal component analysis (PCA) show expected
distribution based on functional and morphological phenotypes. PC1
and PC2 represent greater than 98 % of the variance of the data in
both analyses. (TIFF 24711 kb)
Additional file 4: Figure S2. P10 (a) and P21 (b) browser shots of reads
per million (RPM) normalized mapped read count for selected genes for
each biological replicate show reproducibility of sequencing results
between samples. (ZIP 312 kb)
Additional file 5: Figure S3. Homozygous and heterozygous mutants
show largely overlapping datasets. Venn diagrams comparing significantly
affected transcripts (FC ≥ 2 or ≤ -2, FDR ≤ 0.05 relative to WT) in the
indicated heterozygous and homozygous Crx mutant retinas. (TIFF 14588 kb)
Additional file 6: Figure S4. Crx mutants show little change to other
non-photoreceptor phototransduction components. Heatmap depicts
P10 FC relative to WT for genes involved in phototransduction enriched
in non-photoreceptor retinal cell types in the heterozygous mutants.
(TIFF 14588 kb)
Additional file 7: Figure S5. Heatmap showing the Z-scores comparing
three biological replicates of genes determined to be enriched in either
E168d2/+ (a) or E168d2neo/+ (b) retinas. Genes are arranged in rows,
clustering dendrogram is shown on the left. Patterns of expression
across biological replicates are consistent, supporting the statistical
significance of the difference calculated by EdgeR RNA-seq analysis.
(TIFF 14588 kb)
Additional file 8: Figure S6. Crx mutants show graded changes in
gene expression of overlapping gene sets at P21. a–c Log2 CPM from
P21 heterozygous E168d2/+ (a), E168d2neo/+ (b), and R90W/+ (c) mice
(y-axes) are compared with log2 CPM from age-matched WT C57Bl/6 J
(x-axes) mice. White letters highlight prototypical photoreceptor transcripts.
White diagonal lines represent ±2 FC. d, e Venn diagrams illustrate the
numbers of overlapping and distinct significantly affected genes (FC ≥ 2 or
≤ -2, FDR ≤ 0.05). (TIFF 14588 kb)
Additional file 9: Figure S7. Crx mutants do not abandon the
developmental program, but many genes fail to reach proper expression
levels. a Heatmap, ordered by the magnitude of expression change
between P10 and P21 in WT retina, depicts FC compared with P10 WT to
analyze developmental dynamics. b Top GO terms from analysis of top
100 genes that are down- (left panel) and up- (right panel) regulated
normally during late postnatal retinal development (P21 WT versus P10
WT; FC ≤ −2 or ≥ 2, FDR ≤ 0.05). c Violin and boxplots quantifying
median FC from P10 WT of each mutant. (TIFF 14588 kb)
Additional file 10: Table S3. Compiled table of results from GO
analysis on rod- or cone-enriched genes from Fig. 6a. (XLSX 50 kb)
Additional file 11: Table S4. Compiled ordered lists of heatmap data
presented in the manuscript. (XLSX 148 kb)
Additional file 12: Figure S8. Groups 1, 2, 3, and 6 genes (defined in
Fig. 5) presented as a heatmap with calculated FC values for each
biological replicate compared with the mean age-appropriate WT value.
All genes are ordered exactly as presented in Fig. 5. (TIFF 14588 kb)
Additional file 13: Figure S9. Quantification of normal epigenetic
marks near genes in groups 1, 2, 3, and 6 distinguishes up- and down-
regulated genes in Crx mutants. Control set of equal sized random group of
mm9 genes used as background control (grey in all). a–c Quantification of
CRX ChIP-seq [15] in rod-dominant WT retina (a) and cone-dominant Nrl−/−
retina (b), and NRL ChIP-seq [17] in WT retina (c). d–f DNase I hypersensitivity
plots from WT retina at the three indicated ages [22]. g, h H3K4me2 ChIP-seq
of WT retina at the two ages [23]. i, j H3K27me3 ChIP-seq of WT retina at the
two ages. All represent normalized mean read depth of each library centered
on the TSS of genes within groups 1, 2, 3, and 6. k–n Analysis of WT
expression of each gene and average change in expression (blue line)
from the age of P2 to P21 (raw data in [24]), presented as log2 CPM.
(TIFF 14576 kb)
Additional file 14: Figure S10. Expanded view of areas marked with
asterisks in Fig. 6. All data and presentation exactly as described
previously. (TIFF 14588 kb)
Additional file 15: Figure S11. Changes in rod- and cone-enriched
transcription factors are consistent with general patterns of rod and cone
gene expression in Crx mutants. a, b Heatmap describes FC relative to
WT in each Crx mutant for rod- (a) and cone-enriched (b) genes annotated
as transcription factors (raw data in [24]; WT versus Nrl−/− RNA-seq FC ≤ −2
or ≥2 and FDR ≤ 0.05; GO:0003700). ChIP-seq data are presented for 4-kb
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windows surrounding the TSS for each gene for CRX (in rods and cones)
and NRL (in rods). c Analysis detailing percent of rod-enriched, cone-
enriched, or random set of genes with CRX ChIP-seq peak within 2 kb of
TSS in WT retina. Note the significant enrichment of CRX binding in the rod
set over cone and random gene sets. (TIFF 14588 kb)
Additional file 16: Figure S12. Retinal function is affected by light
damage (LD) in E168d2neo/+ but not E168d2/+ mutant mice. a Intensity-
response plots for dark-adapted ERG a-wave, dark-adapted b-wave and
light-adapted b-wave from mice with the indicated genotypes, with or
without LD treatment. b Intensity-response plots for ERG responses
following LD for mice pretreated with either 13-cis-RA or DMSO. c Rod
dark adaptation measured by recovery of maximal rod ERG a-wave
following >90 % rhodopsin photobleach for WT and E168d2neo/+ mice,
with and without drug treatment. Error bars represent standard error of
mean (n ≥ 3). Asterisks mark data points of significant difference (p ≤0.05)
from the control as determined by two-way ANOVA (see "Materials and
methods"). (TIFF 3018 kb)
Additional file 17: Figure S13. E168d2/+ photoreceptor degeneration
is light-independent. Retinal morphology of E168d2/+ mice raised under
12 h light–dark cycle (normal light) or constant darkness (dark-reared) for
3 or 6 months. Note that the dark rearing did not improve ONL thinning
in the mutant retina. GCL ganglion cell layer, INL inner nuclear layer, IPL
inner plexiform layer, OS outer segment, ONL outer nuclear layer, OPL
outer plexiform layer. Scale bar = 50 μM. (TIFF 3603 kb)
Additional file 18: Figure S14. Increased Crx expression in mutant
lines at P10. a RNA-seq derived raw CPM values for each biological repli-
cate (red circles) and mean (black bar). Top panel of spreadsheet lists the
EdgeR calculated FC and FDR for each genotype relative to WT control.
Asterisks denote samples where FDR < 0.05. b qRT-PCR analysis of transcript
levels of WT and mutant Crx alleles in each genotype. Note the same trend
of Crx expression changes in these mutants detected by both methods.
(TIFF 14588 kb)
Additional file 19: Table S5. List of primers used for qRT-PCR completed
for this manuscript. (XLSX 54 kb)
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